Biotech NewsSyndax (SNDX) Up 15% in 6 Months — Analysts See $56 High BioTech Health XSeptember 17, 2025 Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a biotechnology company dedicated to developing innovative therapies that address some of the… 0 Shares 0 0 0 0 0 0 0